Mangalam Drugs & Organics Limited (BOM:532637)
India
· Delayed Price · Currency is INR 33.17
-0.81 (-2.38%)
At close: Mar 10, 2026
Mangalam Drugs & Organics Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 525 | 1,175 | 1,466 | 1,549 | 1,628 | 1,573 | Upgrade
|
| Market Cap Growth | -69.06% | -19.89% | -5.31% | -4.86% | 3.47% | 227.51% | Upgrade
|
| Enterprise Value | 1,506 | 2,108 | 2,355 | 2,372 | 2,383 | 2,090 | Upgrade
|
| Last Close Price | 33.17 | 74.22 | 92.65 | 97.85 | 102.85 | 99.40 | Upgrade
|
| PE Ratio | - | 17.48 | - | 121.95 | 8.28 | 5.63 | Upgrade
|
| PS Ratio | 0.22 | 0.37 | 0.40 | 0.42 | 0.36 | 0.41 | Upgrade
|
| PB Ratio | 0.41 | 0.79 | 1.08 | 1.02 | 1.08 | 1.20 | Upgrade
|
| P/TBV Ratio | 0.54 | 0.82 | 1.19 | 1.16 | 1.19 | 1.30 | Upgrade
|
| P/FCF Ratio | - | 5.25 | - | 13.34 | - | - | Upgrade
|
| P/OCF Ratio | - | 2.76 | 37.48 | 3.92 | 6.33 | 5.71 | Upgrade
|
| EV/Sales Ratio | 0.63 | 0.66 | 0.64 | 0.64 | 0.53 | 0.55 | Upgrade
|
| EV/EBITDA Ratio | 27.72 | 6.39 | 30.65 | 9.84 | 5.03 | 4.01 | Upgrade
|
| EV/EBIT Ratio | - | 10.78 | 84.17 | 16.21 | 6.14 | 4.70 | Upgrade
|
| EV/FCF Ratio | - | 9.41 | - | 20.43 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.80 | 0.65 | 0.79 | 0.58 | 0.58 | 0.53 | Upgrade
|
| Debt / EBITDA Ratio | 18.67 | 2.74 | 11.42 | 3.53 | 1.81 | 1.31 | Upgrade
|
| Debt / FCF Ratio | - | 4.30 | - | 7.63 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.77 | 0.63 | 0.78 | 0.56 | 0.57 | 0.53 | Upgrade
|
| Net Debt / EBITDA Ratio | 29.04 | 2.84 | 13.77 | 3.56 | 1.82 | 1.33 | Upgrade
|
| Net Debt / FCF Ratio | - | 4.18 | -13.36 | 7.40 | -43.85 | -17.78 | Upgrade
|
| Asset Turnover | - | 0.91 | 1.06 | 1.08 | 1.52 | 1.54 | Upgrade
|
| Inventory Turnover | - | 1.30 | 1.89 | 1.99 | 3.53 | 4.14 | Upgrade
|
| Quick Ratio | - | 0.22 | 0.18 | 0.30 | 0.37 | 0.50 | Upgrade
|
| Current Ratio | - | 1.04 | 1.07 | 1.25 | 1.42 | 1.23 | Upgrade
|
| Return on Equity (ROE) | - | 4.72% | -6.30% | 0.84% | 13.97% | 23.83% | Upgrade
|
| Return on Assets (ROA) | - | 3.49% | 0.50% | 2.66% | 8.19% | 11.24% | Upgrade
|
| Return on Invested Capital (ROIC) | -7.32% | 8.08% | 1.17% | 3.54% | 12.60% | 17.78% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 11.20% | 1.60% | 7.50% | 19.60% | 28.70% | Upgrade
|
| Earnings Yield | -58.89% | 5.72% | -6.19% | 0.82% | 12.07% | 17.78% | Upgrade
|
| FCF Yield | - | 19.06% | -5.40% | 7.50% | -1.20% | -2.47% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | -0.08% | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.